Kiran Mazumdar-Shaw emphasizes policy and funding reforms as essential for India's biotech sector to foster innovation and attract investment.

This paper is authored by Shravishtha Ajaykumar, Lakshmy Ramakrishnan, ORF, New Delhi.

The Biotechnology Industry Organization (BIO) today announces the initial selection of presenting companies for the 3rd Annual , September 12-13 at the Grand Hyatt in Mumbai, India. Through company ...

HYDERABAD, Aug 27 (Reuters) - India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a ...

@JohnCFierce: Big Pharma knows it has a huge development problem, but I don't buy the we'll-act-like-biotechs-from-now-on routine. | Follow @JohnCFierce > India's cancer-drug market, valued at about ...

Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Enterprise set up by the Department of Biotechnology (DBT), marked its 14th Foundation Day, celebrating a decade and a half ...

BENGALURU, Feb 18 (Reuters) - India's Bharat Biotech is in the process of filing regulatory documents for approval of its COVID-19 vaccine, COVAXIN, in more than 40 countries, the company told Reuters ...